Press Coverage

Endomicroscopy system could increase detection of esophageal dysplasia, cancer

13 July 2022

A meta-analysis found that using Cellvizio — a multidisciplinary probe and needle-based confocal laser endomicroscopy system — in tandem with the standard of care to guide biopsies improves diagnosis for dysplasia and cancer and reduces sampling error, according to research published in Techniques and Innovations in Gastrointestinal Endoscopy.

Latest News

Mauna Kea Technologies Expands International Adoption of Cellvizio® for Pancreatic Cystic Lesions with Key Hospital Installations in Spain and the United Arab Emirates

Mauna Kea Technologies Expands International Adoption of Cellvizio® for Pancreatic Cystic Lesions with Key Hospital Installations in Spain and the United Arab Emirates

PANCREATIC CANCER AWARENESS MONTH: UNDERSTANDING CELLVIZIO® IN CLINICAL PRACTICE 

PANCREATIC CANCER AWARENESS MONTH: UNDERSTANDING CELLVIZIO® IN CLINICAL PRACTICE 

Mauna Kea Technologies Announces the Launch of CellTolerance® at Cleveland Clinic Abu Dhabi, the First Hospital in the MENA Region to Offer the Program 

Mauna Kea Technologies Announces the Launch of CellTolerance® at Cleveland Clinic Abu Dhabi, the First Hospital in the MENA Region to Offer the Program 

No results found.